shutterstock_1643947495_andrii_vodolazhskyi

Andrii Vodolazhskyi / Shutterstock.com

7 April 2020Big PharmaSarah Morgan

EU should buy patent rights for COVID-19 tests, says Greece

Greece has reportedly suggested that EU member states should jointly buy patent rights for COVID-19 tests and vaccines to ensure rapid distribution across the EU.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

Israel imports patented antivirals for treating COVID-19

24 March 2020 Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

More on this story

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

Israel imports patented antivirals for treating COVID-19

24 March 2020 Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

More on this story

Costa Rica asks WHO to create voluntary COVID-19 IP pool

26 March 2020 The Costa Rican government has asked the World Health Organization to create a voluntary pool to collect patent rights for technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic.

Israel imports patented antivirals for treating COVID-19

24 March 2020 Israel has approved generic versions of an HIV antiviral owned by AbbVie for use in treating coronavirus, despite the company still holding patent protection and doubts over its effectiveness.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’

BMS unit loses cell therapy patent at European Patent Office

Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market

Lord Justice Birss to become chancellor of the High Court

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?